Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Adaptimmune forms alliance with MD Anderson

Country: United Kingdom

 Adaptimmune Therapeutics Plc and the MD Anderson Cancer Center of the University of Texas have agreed to cooperate on T-cell receptor technology for treating solid and blood cancers.

Read more

GSK names Emma Walmsley as CEO designate

Country: United Kingdom

GlaxoSmithKline Plc has named Emma Walmsley, currently head of the company’s consumer healthcare division, as the successor to Andrew Witty, the chief executive officer. Mr Witty will be retiring on 31 March 2017.

Read more

FDA approves Sarepta drug for DMD

Country: United States

Read more

EMA recommends new cancer drugs

Country: United Kingdom

Read more

UK start-up has new angle on T cell therapy

Country: United Kingdom

Read more

Lundbeck fine upheld; company ponders appeal

Country: Denmark

Read more

Bavarian Nordic, Janssen progress Ebola vaccine

Country: Denmark

Read more

Series C round for Ireland’s Vivasure

Country: Ireland

Read more

Fluidic Analytics raises £5.3 million

Country: United Kingdom

Read more

Bayer to pay $66 billion for Monsanto

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Brexit: Britain looks to life outside the EU

MedNousBriefingBrexitSept2016.pdf

Highlights of the September 2016 MedNous issue

The September 2016 MedNous features:

Latest Mednous cover
  • Business Strategy
    Bioelectronics creates
    new horizon for medicine
  • Research Strategy
    Tackling pneumococcal
    disease with vaccines
    By Chris Bailey
  • Commentary
    Has à la carte genetic medicine arrived?
    By Ali Mortazavi
  • Public Policy
    The perils of Brexit
  • Company News
    Pfizer outbids rivals for Medivation
  • Licensing and Collaboration Briefs

The latest MedNous journal. Subscribe to download.

Recent Appointments